We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IOM Argument to End 510(k)s Is Defended in FDLI Report
IOM Argument to End 510(k)s Is Defended in FDLI Report
January 6, 2012
The FDA should establish a new standard for premarket clearance to tell the difference between products that can be approved based on predicate devices alone and those that need more rigorous postmarket approval, says one legal expert.